Taiwan To Cover Tamiflu Doses For National Health Program Relief
This article was originally published in PharmAsia News
Executive SummaryTaiwan's government has decided to cover the cost of all Tamiflu (oseltamivir) doses in an effort to relieve the cost pressure on the nation's national health insurance agency
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.